To me it looks like manipulation so someone can get some shares on the cheap. If all is well with the Abbott collaboration (which is appears to be) then there is every chance to Phase II and Phase III's will start on time as planned. Once that happens NBIX is a player in late stage biotech again. They'll be on every radar screen and Abbott will of course try to acquire them if/when positive results are announced. This should be trading for twice as much as it is today. I think by the end of the year we'll be looking at a $8-9 stock as long as everything starts okay. If things go really well and the Phase III's are positive then you're looking at perhaps $25. The potential is so huge here..it's unusual. I've been in biotech long enough to know manipulation is alive and well.